Marchex (MCHX) Research & Development (2010 - 2025)

Marchex (MCHX) has 16 years of Research & Development data on file, last reported at $410000.0 in Q4 2025.

• On a quarterly basis, Research & Development fell 84.0% year-over-year to $410000.0 in Q4 2025; TTM through Dec 2025 was $9.1 million, a 22.22% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 19.69% from the prior year.
• Research & Development for Q4 2025 stood at $410000.0, down from $2.9 million in the prior quarter.
• Over the last five years, Research & Development for MCHX reached as high as $5.3 million in Q1 2021 and fell as low as $260000.0 in Q4 2021.
• Historically, Research & Development has averaged $3.1 million across 5 years, with a median of $3.2 million in 2022.
• Across the five-year window, Research & Development jumped 1508.85% in 2022 and tumbled 84.0% in 2025, its largest moves.
• Year by year, Research & Development stood at $260000.0 in 2021, then soared by 1508.85% to $4.2 million in 2022, then slumped by 40.43% to $2.5 million in 2023, then increased by 2.85% to $2.6 million in 2024, then tumbled by 84.0% to $410000.0 in 2025.
• Per Business Quant data, the three most recent Research & Development figures were $410000.0 in Q4 2025, $2.9 million in Q3 2025, and $2.5 million in Q2 2025.